Skip to main content
. Author manuscript; available in PMC: 2019 Feb 11.
Published in final edited form as: Clin Radiol. 2015 Jul 29;70(11):1165–1176. doi: 10.1016/j.crad.2015.06.093

Figure 2.

Figure 2

Differences inT2 scoring for high probability targets. A 77-year-old patient with a PSA of 17 ng/ml. (a)T2W1 shows a large (2.5 × 1.5 cm) lesion centred in the left TZ at the level of the mid-gland (arrow), with matching restricted diffusion (b-c). P1-RADS v1 scores: 4 for T2 as no features of ECE and no broad capsular contact, 5 for DW1. P1-RADS v2 overall score 5: T2 is the dominant sequence and the lesion is >1.5 cm, despite no features of ECE. Subsequent targeted biopsy confirms Gleason 4+5 disease (90% core involvement) in the left medial mid-gland and Gleason 5+5 (60% involvement) in the left posterior lateral gland.